- Home
- IKT vs AVD Comparison
IKT vs AVD Comparison
Compare IKT & AVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- AVD
- Stock Information
- Founded
- IKT 2008
- AVD 1969
- Country
- IKT United States
- AVD United States
- Employees
- IKT N/A
- AVD N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- AVD Agricultural Chemicals
- Sector
- IKT Health Care
- AVD Industrials
- Exchange
- IKT Nasdaq
- AVD Nasdaq
- Market Cap
- IKT 167.2M
- AVD 165.8M
- IPO Year
- IKT 2020
- AVD N/A
- Fundamental
- Price
- IKT $2.20
- AVD $4.70
- Analyst Decision
- IKT Buy
- AVD Strong Buy
- Analyst Count
- IKT 2
- AVD 3
- Target Price
- IKT $8.00
- AVD $16.67
- AVG Volume (30 Days)
- IKT 167.2K
- AVD 191.8K
- Earning Date
- IKT 03-26-2025
- AVD 05-08-2025
- Dividend Yield
- IKT N/A
- AVD 1.27%
- EPS Growth
- IKT N/A
- AVD N/A
- EPS
- IKT N/A
- AVD N/A
- Revenue
- IKT $1.00
- AVD $553,839,000.00
- Revenue This Year
- IKT N/A
- AVD N/A
- Revenue Next Year
- IKT N/A
- AVD $5.98
- P/E Ratio
- IKT N/A
- AVD N/A
- Revenue Growth
- IKT N/A
- AVD N/A
- 52 Week Low
- IKT $1.12
- AVD $4.26
- 52 Week High
- IKT $4.20
- AVD $14.28
- Technical
- Relative Strength Index (RSI)
- IKT 45.02
- AVD 39.15
- Support Level
- IKT $1.91
- AVD $4.38
- Resistance Level
- IKT $2.22
- AVD $4.95
- Average True Range (ATR)
- IKT 0.25
- AVD 0.26
- MACD
- IKT -0.01
- AVD -0.03
- Stochastic Oscillator
- IKT 29.59
- AVD 35.16
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About AVD American Vanguard Corporation ($0.10 Par Value)
American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.